{"transactions":[{"id":3178067,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":149884,"kind":"organization","name":"Arkin Bio Ventures Limited Partnership","position":1,"cik":"0001808348","reported_name":"Arkin Bio Ventures Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149885,"kind":"organization","name":"Arkin Bio Venture Partners Ltd.","position":2,"cik":"0001808349","reported_name":"Arkin Bio Venture Partners Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20291,"kind":"person","name":"Arkin Moshe","position":3,"cik":"0001321178","reported_name":"Arkin Moshe","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-04-13T17:29:33.000Z","date":"2020-04-13","kind":"exercise","acquired":false,"shares":167537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are held by Arkin Bio Ventures Limited Partnership (\"Arkin Bio\"). Arkin Bio Venture Partners Ltd. is the general partner of Arkin Bio. Moshe Arkin is the sole shareholder and chairman of the board of Arkin Bio Venture Partners Ltd.."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":167537},"source":{"system":"sec-edgar","filing":"0001178913-20-001105","document":"zk2024260.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1808348/000117891320001105/zk2024260.xml","form_type":"4"}},{"id":3178066,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":149884,"kind":"organization","name":"Arkin Bio Ventures Limited Partnership","position":1,"cik":"0001808348","reported_name":"Arkin Bio Ventures Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149885,"kind":"organization","name":"Arkin Bio Venture Partners Ltd.","position":2,"cik":"0001808349","reported_name":"Arkin Bio Venture Partners Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20291,"kind":"person","name":"Arkin Moshe","position":3,"cik":"0001321178","reported_name":"Arkin Moshe","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2020-04-13T17:29:33.000Z","date":"2020-04-13","kind":"exercise","acquired":false,"shares":343270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are held by Arkin Bio Ventures Limited Partnership (\"Arkin Bio\"). Arkin Bio Venture Partners Ltd. is the general partner of Arkin Bio. Moshe Arkin is the sole shareholder and chairman of the board of Arkin Bio Venture Partners Ltd.."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":343270},"source":{"system":"sec-edgar","filing":"0001178913-20-001105","document":"zk2024260.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808348/000117891320001105/zk2024260.xml","form_type":"4"}},{"id":3178065,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":149884,"kind":"organization","name":"Arkin Bio Ventures Limited Partnership","position":1,"cik":"0001808348","reported_name":"Arkin Bio Ventures Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149885,"kind":"organization","name":"Arkin Bio Venture Partners Ltd.","position":2,"cik":"0001808349","reported_name":"Arkin Bio Venture Partners Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20291,"kind":"person","name":"Arkin Moshe","position":3,"cik":"0001321178","reported_name":"Arkin Moshe","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-04-13T17:29:33.000Z","date":"2020-04-13","kind":"exercise","acquired":false,"shares":1382295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are held by Arkin Bio Ventures Limited Partnership (\"Arkin Bio\"). Arkin Bio Venture Partners Ltd. is the general partner of Arkin Bio. Moshe Arkin is the sole shareholder and chairman of the board of Arkin Bio Venture Partners Ltd.."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1382295},"source":{"system":"sec-edgar","filing":"0001178913-20-001105","document":"zk2024260.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808348/000117891320001105/zk2024260.xml","form_type":"4"}},{"id":3178064,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":149884,"kind":"organization","name":"Arkin Bio Ventures Limited Partnership","position":1,"cik":"0001808348","reported_name":"Arkin Bio Ventures Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149885,"kind":"organization","name":"Arkin Bio Venture Partners Ltd.","position":2,"cik":"0001808349","reported_name":"Arkin Bio Venture Partners Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20291,"kind":"person","name":"Arkin Moshe","position":3,"cik":"0001321178","reported_name":"Arkin Moshe","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T17:29:33.000Z","date":"2020-04-13","kind":"purchase","acquired":true,"shares":120000,"price":16,"value":1920000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are held by Arkin Bio Ventures Limited Partnership (\"Arkin Bio\"). Arkin Bio Venture Partners Ltd. is the general partner of Arkin Bio. Moshe Arkin is the sole shareholder and chairman of the board of Arkin Bio Venture Partners Ltd.."}],"balance_after":2013102,"source":{"system":"sec-edgar","filing":"0001178913-20-001105","document":"zk2024260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808348/000117891320001105/zk2024260.xml","form_type":"4"}},{"id":3178063,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":149884,"kind":"organization","name":"Arkin Bio Ventures Limited Partnership","position":1,"cik":"0001808348","reported_name":"Arkin Bio Ventures Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149885,"kind":"organization","name":"Arkin Bio Venture Partners Ltd.","position":2,"cik":"0001808349","reported_name":"Arkin Bio Venture Partners Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20291,"kind":"person","name":"Arkin Moshe","position":3,"cik":"0001321178","reported_name":"Arkin Moshe","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T17:29:33.000Z","date":"2020-04-13","kind":"exercise","acquired":true,"shares":167537,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are held by Arkin Bio Ventures Limited Partnership (\"Arkin Bio\"). Arkin Bio Venture Partners Ltd. is the general partner of Arkin Bio. Moshe Arkin is the sole shareholder and chairman of the board of Arkin Bio Venture Partners Ltd.."}],"balance_after":1893102,"source":{"system":"sec-edgar","filing":"0001178913-20-001105","document":"zk2024260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808348/000117891320001105/zk2024260.xml","form_type":"4"}},{"id":3178062,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":149884,"kind":"organization","name":"Arkin Bio Ventures Limited Partnership","position":1,"cik":"0001808348","reported_name":"Arkin Bio Ventures Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149885,"kind":"organization","name":"Arkin Bio Venture Partners Ltd.","position":2,"cik":"0001808349","reported_name":"Arkin Bio Venture Partners Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20291,"kind":"person","name":"Arkin Moshe","position":3,"cik":"0001321178","reported_name":"Arkin Moshe","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T17:29:33.000Z","date":"2020-04-13","kind":"exercise","acquired":true,"shares":343270,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are held by Arkin Bio Ventures Limited Partnership (\"Arkin Bio\"). Arkin Bio Venture Partners Ltd. is the general partner of Arkin Bio. Moshe Arkin is the sole shareholder and chairman of the board of Arkin Bio Venture Partners Ltd.."}],"balance_after":1725565,"source":{"system":"sec-edgar","filing":"0001178913-20-001105","document":"zk2024260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808348/000117891320001105/zk2024260.xml","form_type":"4"}},{"id":3178061,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":149884,"kind":"organization","name":"Arkin Bio Ventures Limited Partnership","position":1,"cik":"0001808348","reported_name":"Arkin Bio Ventures Limited Partnership","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149885,"kind":"organization","name":"Arkin Bio Venture Partners Ltd.","position":2,"cik":"0001808349","reported_name":"Arkin Bio Venture Partners Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20291,"kind":"person","name":"Arkin Moshe","position":3,"cik":"0001321178","reported_name":"Arkin Moshe","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T17:29:33.000Z","date":"2020-04-13","kind":"exercise","acquired":true,"shares":1382295,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock converted into shares of Common Stock upon the closing of the Issuer's initial public offering, on a one-for-one basis, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are held by Arkin Bio Ventures Limited Partnership (\"Arkin Bio\"). Arkin Bio Venture Partners Ltd. is the general partner of Arkin Bio. Moshe Arkin is the sole shareholder and chairman of the board of Arkin Bio Venture Partners Ltd.."}],"balance_after":1382295,"source":{"system":"sec-edgar","filing":"0001178913-20-001105","document":"zk2024260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808348/000117891320001105/zk2024260.xml","form_type":"4"}}]}